Editor’s Choice- Pathophysiology,diagnosis and management of MINOCA: an update

Abstract

Myocardial infarction with non-obstructive coronary arteries (MINOCA) is a syndrome with different causes, characterised by clinical evidence of myocardial infarction with normal or near-normal coronary arteries on angiography. Its prevalence ranges between 5% and 25% of all myocardial infarction. The prognosis is extremely variable, depending on the cause of MINOCA. The key principle in the management of this syndrome is to clarify the underlying individual mechanisms to achieve patient-specific treatments. Clinical history, electrocardiogram, cardiac enzymes, echocardiography, coronary angiography and left ventricular angiography represent the first level diagnostic investigations to identify the causes of MINOCA. Regional wall motion abnormalities at left ventricular angiography limited to a single epicardial coronary artery territory identify an ‘epicardial pattern’whereas regional wall motion abnormalities extended beyond a single epicardial coronary artery territory identify a ‘microvascular pattern’. The most common causes of MINOCA are represented by coronary plaque disease, coronary dissection, coronary artery spasm, coronary microvascular spasm, Takotsubo cardiomyopathy, myocarditis, coronary thromboembolism, other forms of type 2 myocardial infarction and MINOCA of uncertain aetiology. This review aims at summarising the diagnosis and management of MINOCA, according to the underlying physiopathology.

Keywords

Myocardial infarction non-obstructive coronary artery disease

Get full access to this article

View all access options for this article.

References

Niccoli

Scalone

Crea

Acute myocardial infarction with no obstructive coronary atherosclerosis: mechanisms and management. Eur Heart J 2015; 36: 475–481.

Ibanez

James

Agewall

et al ; ESC Scientific Document Group. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the Management of Acute Myocardial Infarction in Patients Presenting with ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J 2018; 39: 119–177.

Bugiardini

Manfrini

De Ferrari

GM.

Unanswered questions for management of acute coronary syndrome: risk stratification of patients with minimal disease or normal findings on coronary angiography. Arch Intern Med 2006; 166: 1391–1395.

Gehrie

Reynolds

Chen

et al . Characterization and outcomes of women and men with non-ST-segment elevation myocardial infarction and nonobstructive coronary artery disease: results from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines (CRUSADE) quality improvement initiative. Am Heart J 2009; 158: 688–694.

Bugiardini

Bairey Merz

CN.

Angina with “normal” coronary arteries: a changing philosophy. JAMA 2005; 293: 477–484.

Crea

Camici

De Caterina

et al . Chronic ischaemic heart disease. In: Camm

Lȕscher

Serruys

(eds) The ESC Textbook of Cardiovascular Medicine. New York, NY: Oxford University Press, 2009: pp. 657–660.

Planer

Mehran

Ohman

et al . Prognosis of patients with non-ST-segment-elevation myocardial infarction and nonobstructive coronary artery disease: propensity-matched analysis from the Acute Catheterization and Urgent Intervention Triage Strategy Trial. Circ Cardiovasc Interv 2014; 7: 285–293.

Kang

Jeong

Ahn

et al.;

Korea Acute Myocardial Infarction Registry Investigators. Are patients with angiographically near-normal coronary arteries who present as acute myocardial infarction actually safe?

Int J Cardiol 2011; 146: 207–212.

Larsen

Nilsen

et al . Long-term prognosis of patients presenting with ST segment elevation myocardial infarction with no significant coronary artery disease (from the Horizons-AMI trial). Am J Cardiol 2013; 111: 643–648.

10.

Daniel

Agewall

Caidahl

et al . Effect of myocardial infarction with nonobstructive coronary arteries on physical capacity and quality-of-life. Am J Cardiol 2017; 120: 341–346.

11.

Pasupathy

Air

Dreyer

et al . Systematic review of patients presenting with suspected myocardial infarction and nonobstructive coronary arteries. Circulation 2015; 131: 861–870.

12.

Agewall

Beltrame

Reynolds

et al.;

Working Group on Cardiovascular Pharmacotherapy. ESC working group position paper on myocardial infarction with non-obstructive coronary arteries. Eur Heart J 2017; 38: 143–153.

13.

Thygesen

Alpert

Jaffe

et al . Third universal definition of myocardial infarction. Eur Heart J 2012; 33: 2551–2567.

14.

Reynolds

Srichai

Iqbal

et al . Mechanisms of myocardial infarction in women without angiographically obstructive coronary artery disease. Circulation 2011; 124: 1414–1425.

15.

Ouldzein

Elbaz

Roncalli

et al . Plaque rupture and morphological characteristics of the culprit lesion in acute coronary syndromes without significant angiographic lesion: analysis by intravascular ultrasound. Ann Cardiol Angiol 2012; 61: 20–26.

16.

Jia

Abtahian

Aguirre

et al . In vivo diagnosis of plaque erosion and calcified nodule in patients with acute coronary syndrome by intravascular optical coherence tomography. J Am Coll Cardiol 2013; 62: 1748–1758.

17.

Iqbal

Feit

Mancini

GBJ

et al . Characteristics of plaque disruption by intravascular ultrasound in women presenting with myocardial infarction without obstructive coronary artery disease. Am Heart J 2014; 167: 715–722.

18.

Reynolds

Srichai

Iqbal

et al . Mechanisms of myocardial infarction in women without angiographically obstructive coronary artery disease. Circulation 2011; 124: 1414–1425.

19.

Patel

Chen

Peterson

et al . Prevalence, predictors, and outcomes of patients with non-ST-segment elevation myocardial infarction and insignificant coronary artery disease: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines (CRUSADE) initiative. Am Heart J 2006; 152: 641–647.

20.

Roe

Harrington

Prosper

et al . Clinical and therapeutic profile of patients presenting with acute coronary syndromes who do not have significant coronary artery disease. The platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial investigators. Circulation 2000; 102: 1101–1106.

21.

Rossini

Capodanno

Lettieri

et al . Long-term outcomes of patients with acute coronary syndrome and nonobstructive coronary artery disease. Am J Cardiol 2013; 112: 150–155.

22.

Authors/Task Force Members, Roffi

Patrono

Collet

et al . 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J 2016; 37: 267–315.

23.

Alfonso

Paulo

Dutary

Endovascular imaging of angiographically invisible spontaneous coronary artery dissection. JACC Cardiovasc Interv 2012; 5: 452–453.

24.

Antonsen

Thayssen

Jensen

LO.

Large coronary intramural hematomas: a case series and focused literature review. Cardiovasc Revasc Med 2015; 16: 116–123.

25.

Saw

Mancini

Humphries

et al . Angiographic appearance of spontaneous coronary artery dissection with intramural hematoma proven on intracoronary imaging. Catheter Cardiovasc Interv 2016; 87: E54–E61.

26.

Saw

Aymong

Mancini

et al . Nonatherosclerotic coronary artery disease in young women. Can J Cardiol 2014; 30: 814–819.

27.

Saw

Aymong

Sedlak

et al . Spontaneous coronary artery dissection: association with predisposing arteriopathies and precipitating stressors and cardiovascular outcomes. Circ Cardiovasc Interv 2014; 7: 645–655.

28.

Hayes

Pitta

et al . Clinical features, management, and prognosis of spontaneous coronary artery dissection. Circulation 2012; 126: 579–588.

29.

Eleid

Best

et al . Spontaneous coronary artery dissection: revascularization versus conservative therapy. Circ Cardiovasc Interv 2014; 7: 777–786.

30.

Kaski

Crea

Meran

et al . Local coronary supersensitivity to diverse vasoconstrictive stimuli in patients with variant angina. Circulation 1986; 74: 1255–1265.

31.

Pristipino

Beltrame

Finocchiaro

et al . Major racial differences in coronary constrictor response between Japanese and Caucasians with recent myocardial infarction. Circulation 2000; 101: 1102–1108.

32.

Montone

Niccoli

Fracassi

et al . Patients with acute myocardial infarction and non-obstructive coronary arteries: safety and prognostic relevance of invasive coronary provocative tests. Eur Heart J 2018; 39: 91–98.

33.

Lanza

Sestito

Sgueglia

et al . Current clinical features, diagnostic assessment and prognostic determinants of patients with variant angina. Int J Cardiol 2007; 118: 41–47.

34.

Lanza

Crea

Primary coronary microvascular dysfunction: clinical presentation, pathophysiology, and management. Circulation 2010; 121: 2317–2325.

35.

Mohri

Koyanagi

Egashira

et al . Angina pectoris caused by coronary microvascular spasm. Lancet 1998; 351: 1165–1169.

36.

Ong

Camici

Beltrame

et al.;

Coronary Vasomotion Disorders International Study Group (COVADIS). International standardization of diagnostic criteria for microvascular angina. Int J Cardiol 2018; 250: 16–20.

37.

Masumoto

Mohri

Takeshita

Three-year follow-up of the Japanese patients with microvascular angina attributable to coronary microvascular spasm. Int J Cardiol 2001; 81: 151–156.

38.

Arrebola-Moreno

Arrebola

Moral-Ruiz

et al . Coronary microvascular spasm triggers transient ischemic left ventricular diastolic abnormalities in patients with chest pain and angiographically normal coronary arteries. Atherosclerosis 2014; 236: 207–214.

39.

Crea

Bairey Merz

Beltrame

et al . The parallel tales of microvascular angina and heart failure with preserved ejection fraction: a paradigm shift. Eur Heart J 2017; 38: 473–477.

40.

Bybee

Kara

Prasad

et al . Systematic review: transient left ventricular apical ballooning: a syndrome that mimics ST-segment elevation myocardial infarction. Ann Int Med 2004; 141: 858–865.

41.

Prasad

Apical ballooning syndrome: an important differential diagnosis of acute myocardial infarction. Circulation 2007; 115: e56–e59.

42.

Pelliccia

Greco

Vitale

et al . Takotsubo (stress cardiomyopathy). Am J Med 2014; 127: 699–704.

43.

Prasad

Lerman

Rihal

CS.

Apical ballooning syndrome (Tako-Tsubo or stress cardiomyopathy): a mimic of acute myocardial infarction. Am Heart J 2008; 155: 408–417.

44.

Madhavan

Rihal

Lerman

et al . Acute heart failure in apical ballooning syndrome (TakoTsubo/stress cardiomyopathy): clinical correlates and Mayo Clinic risk score. J Am Coll Cardiol 2011; 57: 1400–1401.

45.

Galiuto

De Caterina

Porfidia

et al . Reversible coronary microvascular dysfunction: a common pathogenetic mechanism in apical ballooning or takotsubo syndrome. Eur Heart J 2010; 31: 1319–1327.

46.

Collste

Sörensson

Frick

et al . Myocardial infarction with normal coronary arteries is common and associated with normal findings on cardiovascular magnetic resonance imaging: results from the Stockholm Myocardial Infarction with Normal Coronaries study. J Intern Med 2013; 273: 189–196.

47.

Cacciotti

Passaseo

Marazzi

et al . Observational study on Takotsubo-like cardiomyopathy: clinical features, diagnosis, prognosis and follow-up. BMJ Open 2012; 5: e001165.

48.

Elesber

Prasad

Lennon

et al . Four-year recurrence rate and prognosis of the apical ballooning syndrome. J Am Coll Cardiol 2007; 50: 448–452.

49.

Templin

Ghadri

Diekmann

et al . Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy. N Engl J Med 2015; 373: 929–938.

50.

Tornvall

Gerbaud

Behaghel

et al . A meta-analysis of individual data regarding prevalence and risk markers for myocarditis and infarction determined by cardiac magnetic resonance imaging in myocardial infarction with non-obstructive coronary artery disease. Atherosclerosis 2015; 241: 87–91.

51.

Mahrholdt

Wagner

Deluigi

et al . Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation 2006; 114: 1581–1590.

52.

Kühl

Pauschinger

Bock

et al . Parvovirus B19 infection mimicking acute myocardial infarction. Circulation 2003; 108: 945–950.

53.

Yilmaz

Mahrholdt

Athanasiadis

et al . Coronary vasospasm as the underlying cause for chest pain in patients with PVB19 myocarditis. Heart 2008; 94: 1456–1463.

54.

Caforio

ALP

Pankuweit

Arbustini

et al . Current state of knowledge on aetiology, diagnosis, management and therapy of myocarditis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2013; 34: 2636–2648.

55.

Leone

Veinot

Angelini

et al . 2011 Consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology. Cardiovasc Pathol 2012; 21: 245–274.

56.

Caforio

ALP

Marcolongo

Jahns

et al . Immune-mediated and autoimmune myocarditis: clinical presentation, diagnosis and management. Heart Fail Rev 2013; 18: 715–732.

57.

Bock

Klingel

Kandolf

Human parvovirus B19-associated myocarditis. N Engl J Med 2010; 362: 1248–1249.

58.

Caforio

ALP

Keeling

Zachara

et al . Evidence from family studies for autoimmunity in dilated cardiomyopathy. Lancet 1994; 344: 773–777.

59.

Caforio

Mahon

Baig

et al . Prospective familial assessment in dilated cardiomyopathy. Cardiac autoantibodies predict disease development in asymptomatic relatives. Circulation 2007; 115: 76–83.

60.

Maron

Towbin

Thiene

et al . Contemporary definitions and classification of cardiomyopathies. An American Heart Association scientific statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee, quality of Care and Outcome Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups: and Council on Epidemiology and Prevention. Circulation 2006; 113: 1807–1816.

61.

Elliott

Andersson

Arbustini

et al . Classification of the cardiomyopathies: a position statement from the European Society of Cardiology working group on myocardial and pericardial disease. Eur Heart J 2007; 29: 270–276.

62.

Lurz

Eitel

Adam

et al . Diagnostic performance of CMR imaging compared with EMB in patients with suspected myocarditis. JACC Cardiovasc Imaging 2012; 5: 513–524.

63.

Adler

Charron

Imazio

et al . 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: the Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC). Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2015; 36: 2921–2964.

64.

Kindermann

Kandolf

et al . Predictors of outcome in patients with suspected myocarditis. Circulation 2008; 118: 639–648.

65.

Kuhl

Lassner

von Schlippenbach

et al . Interferon-beta improves survival in enterovirus-associated cardiomyopathy. J Am Coll Cardiol 2012; 60: 1295–1296.

66.

Pasupathy

Air

Dreyer

et al . Systematic review of patients presenting with suspected myocardial infarction and non-obstructive coronary arteries (MINOCA). Circulation 2015; 131: 861–870.

67.

Cuculi

Togni

Meier

Myocardial infarction due to paradoxical embolism in a patient with large atrial septal defect. J Invasive Cardiol 2009; 21: E184–E186.

68.

Crump

Shandling

Van Natta

et al . Prevalence of patent foramen ovale in patients with acute myocardial infarction and angiographically normal coronary arteries. Am J Cardiol 2000; 85: 1368–1370.

69.

Sastry

Riding

Morris

et al . Young Adult Myocardial Infarction and Ischemic Stroke: the role of paradoxical embolism and thrombophilia (The YAMIS Study). J Am Coll Cardiol 2006; 48: 686–691.

70.

Srivastava

Payment

MF.

Images in clinical medicine. Paradoxical embolism thrombus in transit through a patent foramen ovale. N Engl J Med 1997; 337: 681.

71.

Wohrle

Kochs

Hombach

et al . Prevalence of myocardial scar in patients with cryptogenic cerebral ischemic events and patent foramen ovale. JACC Cardiovasc Imaging 2010; 3: 8339.

72.

Meier

Kalesan

Mattle

et al . Percutaneous closure of patent foramen ovale in cryptogenic embolism. N Engl J Med 2013; 368: 1083–1091.

73.

Søndergaard

Kasner

Rhodes

et al . patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke. N Engl J Med 2017; 377: 1033–1042.

74.

Mas

Derumeaux

Guillon

et al.

patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke. N Engl J Med 2017; 377: 1011–1021.

75.

Gerbaud

Harcaut

Coste

et al . Cardiac magnetic resonance imaging for the diagnosis of patients presenting with chest pain, raised troponin, and unobstructed coronary arteries. Int J Cardiovasc Imaging 2012; 28: 783–794.

76.

Stensaeth

Fossum

Hoffmann

et al . Clinical characteristics and role of early cardiac magnetic resonance imaging in patients with suspected ST-elevation myocardial infarction and normal coronary arteries. Int J Cardiovasc Imaging 2011; 27: 355–365.

77.

Baccouche

Mahrholdt

Meinhardt

et al . Diagnostic synergy of non-invasive cardiovascular magnetic resonance and invasive endomyocardial biopsy in troponin-positive patients without coronary artery disease. Eur Heart J 2009; 30: 2869–2879.

78.

Leurent

Langella

Fougerou

et al . Diagnostic contributions of cardiac magnetic resonance imaging in patients presenting with elevated troponin, acute chest pain syndrome and unobstructed coronary arteries. Arch Cardiovasc Dis 2011; 104: 161–170.

79.

Ong

Athanasiadis

Hill

et al . Coronary artery spasm as a frequent cause of acute coronary syndrome: the CASPAR (Coronary Artery Spasm in Patients with Acute Coronary Syndrome) Study. J Am Coll Cardiol 2008; 52: 523–527.